Literature DB >> 8824365

Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.

L Zhang1, W J Blot, W C You, Y S Chang, R W Kneller, M L Jin, J Y Li, L Zhao, W D Liu, J S Zhang, J L Ma, I M Samloff, P Correa, M J Blaser, G W Xu, J F Fraumeni.   

Abstract

Helicobacter pylori infection is a major cause of gastritis and may be a key risk factor for stomach cancer, but its role in the process of gastric carcinogenesis is not well understood. Herein, we examine H. pylori prevalence in relation to demographic and lifestyle factors and to severity of precancerous lesions in an area of China with one of the highest rates of stomach cancer in the world. H. pylori serum IgG antibody positivity was assayed among 2646 adults, ages 35-64, participating in a population-based gastroscopic screening survey in the high-risk area. The prevalence of positivity was evaluated according to gastric histology, environmental and lifestyle variables determined by interviews during the screening, and level of serum pepsinogens. The odds of advanced precancerous lesions (intestinal metaplasia and dysplasia) of the stomach among those with antibody positivity were estimated by logistic regression. Seventy-two % of the population was H. pylori antibody-positive, with nonsignificant variation by sex, age, income, education, family size, and cigarette smoking habits. H. pylori positivity was higher among those who ate sour pancakes, a fermented indigenous staple that is a risk factor for gastric dysplasia and stomach cancer in this population. The prevalence of H. pylori varied most notably, however, with gastric pathology. The percent of H. pylori positivity increased from 55 to 60 to 87% among those with superficial (nonatrophic) gastritis, mild chronic atrophic gastritis, and severe chronic atrophic gastritis, respectively, before falling to 78% among those with intestinal metaplasia or dysplasia. H. pylori antibody positivity also was strongly correlated with serum pepsinogen concentrations, particularly pepsinogen II, but knowledge of H. pylori status did not markedly improve serological identification of advanced precancerous lesions above that provided by pepsinogen ratios alone. The findings suggest that H. pylori infection contributes to the process of gastric carcinogenesis, particularly during the early stages, in this high-risk area.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8824365

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  23 in total

1.  Gastric cancer and H pylori.

Authors:  S M Dawsey; S D Mark; P R Taylor; P J Limburg
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

2.  Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy.

Authors:  Lian Zhang; Lin Shen; Jun-Ling Ma; Kai-Feng Pan; Wei-Dong Liu; Jie Li; Shu-Dong Xiao; San-Ren Lin; Meinhard Classen; Wei-Cheng You
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

3.  Gastric cancer screening using the serum pepsinogen test method.

Authors:  Kazumasa Miki
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

4.  Antigenic characterization of Helicobacter pylori strains from different parts of the world.

Authors:  J Höök-Nikanne; G I Perez-Perez; M J Blaser
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

5.  Cancer prevention and control: alarming challenges in China.

Authors:  Ann M Bode; Zigang Dong; Hongyang Wang
Journal:  Natl Sci Rev       Date:  2015-08-29       Impact factor: 17.275

6.  HLA polymorphisms are associated with Helicobacter pylori infected gastric cancer in a high risk population, China.

Authors:  Zhaohui Li; Dafang Chen; Chunfeng Zhang; Yong Li; Bangwei Cao; Tao Ning; Yiming Zhao; Weicheng You; Yang Ke
Journal:  Immunogenetics       Date:  2005-01-14       Impact factor: 2.846

7.  Association of genetic polymorphisms of interleukins with gastric cancer and precancerous gastric lesions in a high-risk Chinese population.

Authors:  Yu-Mei Wang; Zhe-Xuan Li; Fu-Bing Tang; Yang Zhang; Tong Zhou; Lian Zhang; Jun-Ling Ma; Wei-Cheng You; Kai-Feng Pan
Journal:  Tumour Biol       Date:  2015-09-10

8.  Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening.

Authors:  Susumu Aikou; Yasukazu Ohmoto; Toshiaki Gunji; Nobuyuki Matsuhashi; Hiroshi Ohtsu; Hirona Miura; Kensuke Kubota; Yukinori Yamagata; Yasuyuki Seto; Atsushi Nakajima; James R Goldenring; Michio Kaminishi; Sachiyo Nomura
Journal:  Gastroenterology       Date:  2011-05-27       Impact factor: 22.682

9.  Racial and tissue-specific cancer risk associated with PARP1 (ADPRT) Val762Ala polymorphism: a meta-analysis.

Authors:  Noel Pabalan; Ofelia Francisco-Pabalan; Hamdi Jarjanazi; Hong Li; Lillian Sung; Hilmi Ozcelik
Journal:  Mol Biol Rep       Date:  2012-10-17       Impact factor: 2.316

10.  Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma.

Authors:  Mário Dinis-Ribeiro; Altamiro da Costa-Pereira; Carlos Lopes; Joana Barbosa; Mateus Guilherme; Luís Moreira-Dias; Helena Lomba-Viana; Rui Silva; Nuno Abreu; Rafael Lomba-Viana
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.